Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT03767348
Title Study of RP1 Monotherapy and RP1 in Combination With Nivolumab (IGNYTE)
Acronym IGNYTE
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Replimune Inc.
Age Groups: senior | adult
Covered Countries USA | GBR | FRA | ESP | DEU

No variant requirements are available.